Navigation Links
Modified antibiotic may support fight cancer

According to recent experiments a molecule related to tetracycline can aid stop the spread of cancer cells. Researchers at the University of Iowa have been looking at a new drug called COL-3,// which is related to the well-known antibiotic tetracycline. In a series of experiments, they find that COL-3 acts upon the tissue surrounding a tumour, making that tumour less likely to spread throughout the body.

COL-3 appears to block some of the chemical signals that come from an existing tumour that otherwise encourage cancer cells' movement throughout the surrounding tissue. It may be that COL-3 would be useful in conjunction with conventional anti-cancer drugs which kill cancer cells. Further research will reveal whether this new approach is applicable to the long-term management of human cancer.


Page: 1

Related medicine news :

1. Malaria To Be Tackled By Genetically Modified Mosquitoes
2. Stroke Rehabilitation Through Modified Video Games
3. Genetically Modified Cells Attack Tumors
4. TB can Be Eradicated in the U.S With Modified Guidelines: Study
5. Modified Ligament Surgery Improves Outcomes Players, Athletes
6. New antibiotic already developing resistance
7. Gene clue to antibiotics
8. Excessive use of antibiotics for sore throat
9. E. coli strains resistant to a common antibiotic
10. Cost-effective antibiotics for sinusitis treatment
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:

(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from reveals that behind the tendency to set low expectations ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
Breaking Medicine Technology: